Actinium Pharmaceuticals Valuation
| ATNM Stock | USD 7.06 0.10 1.44% |
At this time, the firm appears to be overvalued. Actinium Pharmaceuticals shows a prevailing Real Value of $6.64 per share. The current price of the firm is $7.06. Our model approximates the value of Actinium Pharmaceuticals from analyzing the firm fundamentals such as Shares Outstanding of 29.4 M, return on equity of -0.95, and Operating Margin of (127.69) % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Actinium Pharmaceuticals' valuation include:
Price Book 7.2725 | Enterprise Value 136.2 M | Enterprise Value Ebitda (3.72) | Price Sales 3.3 K | Forward PE 6.8399 |
Overvalued
Today
Please note that Actinium Pharmaceuticals' price fluctuation is relatively risky at this time. Calculation of the real value of Actinium Pharmaceuticals is based on 3 months time horizon. Increasing Actinium Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Actinium Pharmaceuticals is useful when determining the fair value of the Actinium stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Actinium Pharmaceuticals. Since Actinium Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Actinium Stock. However, Actinium Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.06 | Real 6.64 | Target 27.6 | Hype 6.96 | Naive 4.99 |
The real value of Actinium Stock, also known as its intrinsic value, is the underlying worth of Actinium Pharmaceuticals Company, which is reflected in its stock price. It is based on Actinium Pharmaceuticals' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Actinium Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Actinium Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Actinium Pharmaceuticals helps investors to forecast how Actinium stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Actinium Pharmaceuticals more accurately as focusing exclusively on Actinium Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Actinium Pharmaceuticals' intrinsic value based on its ongoing forecasts of Actinium Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Actinium Pharmaceuticals' closest peers. When choosing an evaluation method for Actinium Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Actinium Pharmaceuticals Investments |
|
Actinium Valuation Trend
Knowing Actinium Pharmaceuticals' actual value is paramount for traders to make sound investment determinations. Actinium Pharmaceuticals' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Actinium Pharmaceuticals' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Actinium Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Actinium Market Cap
Actinium Pharmaceuticals is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 37.02 Billion. Actinium Pharmaceuticals maintains roughly 204.6 Million in market capitalization contributing less than 1% to equities under Health Care industry.Actinium Pharmaceuticals Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Actinium Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Actinium Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Actinium Pharmaceuticals competition to find correlations between indicators driving Actinium Pharmaceuticals's intrinsic value. More Info.Actinium Pharmaceuticals is rated fourth in price to earning category among related companies. It is rated below average in price to book category among related companies . As of the 24th of April 2024, Price To Book Ratio is likely to grow to 3.90. Comparative valuation analysis is a catch-all model that can be used if you cannot value Actinium Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Actinium Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Actinium Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Actinium Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Actinium Pharmaceuticals and how it compares across the competition.
About Actinium Pharmaceuticals Valuation
The stock valuation mechanism determines the current worth of Actinium Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Actinium Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Actinium Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Actinium Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Actinium Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Actinium Pharmaceuticals. We calculate exposure to Actinium Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Actinium Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -709 K | -673.5 K | |
| Pretax Profit Margin | (602.69) | (572.56) | |
| Operating Profit Margin | (640.99) | (608.94) | |
| Net Loss | (693.10) | (658.44) | |
| Gross Profit Margin | (8.75) | (8.32) |
8 Steps to conduct Actinium Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Actinium Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Actinium Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Actinium Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Actinium Pharmaceuticals' revenue streams: Identify Actinium Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Actinium Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Actinium Pharmaceuticals' growth potential: Evaluate Actinium Pharmaceuticals' management, business model, and growth potential.
- Determine Actinium Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Actinium Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Actinium Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Actinium Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 26.6 M | |
| Forward Price Earnings | 6.8399 |
Actinium Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Actinium Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Actinium we look at many different elements of the entity such as Actinium's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Actinium Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Actinium Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Actinium Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Actinium Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Actinium Pharmaceuticals' worth.When determining whether Actinium Pharmaceuticals is a strong investment it is important to analyze Actinium Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Actinium Pharmaceuticals' future performance. For an informed investment choice regarding Actinium Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinium Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Actinium Stock analysis
When running Actinium Pharmaceuticals' price analysis, check to measure Actinium Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Actinium Pharmaceuticals is operating at the current time. Most of Actinium Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Actinium Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Actinium Pharmaceuticals' price. Additionally, you may evaluate how the addition of Actinium Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Actinium Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.83) | Revenue Per Share 0.003 | Quarterly Revenue Growth (1.00) | Return On Assets (0.33) | Return On Equity (0.95) |
The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.